Raymond James upgrades DR Horton to 'outperform' with a price target of $160.00

An analyst from Raymond James upgraded DR Horton (NYSE: DHI ) from 'market perform' to 'outperform' with a price target of $160.00.
Prior to this rating, DR Horton had 11 buy ratings, 10 hold ratings, and 1 sell ratings.
For consensus analyst estimates and price targets on DR Horton, click here. For more news on DR Horton, click here.
DR Horton's stock price closed at $127.58. They are up 5.96% in the last month and up 69.29% in the last 12 months.
According to Investing Pro, DR Horton's fair value is $157.49, an upside of 23.45%. DR Horton's fair value comes with a medium degree of uncertainty, according to InvestingPro.
Check out DR Horton's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or